Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
A vial of the Comirnaty Covid-19 vaccine from Pfizer/BioNTech on June 14, 2021
A vial of the Comirnaty Covid-19 vaccine from Pfizer/BioNTech on June 14, 2021 - Credit: Mika Baumeister / Unsplash - License: Unsplash
Health
Politics
Coronavirus
Covid-19
covid-19 vaccine
NVK
Dutch Association of Pediatrics
Karoly Illy
Outbreak Management Team
Hugo de Jonge
Monday, 28 June 2021 - 18:40
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Dutch pediatricians now support vaccinating 12-17 year olds against Covid-19

The Dutch pediatrics association (NVK) said it is now in favor of vaccinating all children between the ages of 12 and 17 against Covid-19, and not only those who are part of a medical risk group. A key reason to inoculate them against the disease is to prevent further spread of the SARS-CoV-2 coronavirus, the organization said.

“The most important consideration is that it has a significant effect against the spread of the more contagious delta variant,” said Károly Illy, the chair of the NVK, in an interview with NOS on Monday.

Earlier this month, the organization said there was not enough information to issue advice on the topic. That was because the medical risk connected to Covid-19 in teenagers is very small, Illy told the Volkskrant.

“But it is clear from the latest models that predict the spread of the disease that, if teenagers are not vaccinated, the number of infections will rise sharply after the summer. That increase is significantly higher than if the teenagers were vaccinated,” Illy said to the newspaper.

The ethical decision of vaccinating a large group of people against a disease that might not affect them adversely was outweighed by the prospect of enhanced social restrictions caused by an outbreak of the coronavirus infection. “It is also not good for teenagers if society again ends up in a semi-lockdown in the fall,” he said.

“Or if there is another discussion about whether the schools should be closed. We really don’t want that anymore.”

Data about side effects experienced by the age group when vaccinated also helped sway Illy’s mind. The Pfizer Covid-19 vaccine is approved for use in Europe for children aged 12 to 17, but the Netherlands has so far only allowed the vaccine to be used on children in certain risk categories.

The NVK has analyzed more data from the United States, Canada, and several European countries where the vaccine is used more widely.

“Thanks to that data, we now have much more insight into the very rare side effects in this age group," he told NOS. The primary rare side effect is myocarditis, or inflammation of the heart muscle, which is temporary and can be treated when doctors, patients, and parents pay attention to symptoms.

Health Minister Hugo de Jonge has said that he is in favor of vaccinating people aged 12 to 17. He said he will make a decision once the Dutch Health Council issues advice on the issue.

Follow us:

Latest stories

  • Oranje beat Gibraltar 3-0 in Rotterdam
  • A €0.15 deposit on 2.5 billion cans per year is a “gigantic operation”
  • XHamster tells court it can’t monitor consent for “old” amateur porn videos
  • Dozens of cars vandalized at Assen auto event
  • Gov't boosts education spending by €216 million; Won’t solve everything, educators say
  • Dutch tax office also wants to ban apps like TikTok from work telephones

Top stories

  • Asylum agency risking people's health by buying cheapest possible care: report
  • Engineering firm Arcadis apologizes for predecessor's role in WWII labor camps
  • One killed in Rotterdam shooting; Two injured arrested
  • Childhood trauma affects women differently than men later in life, study finds
  • Scientist Rebellion activists blindfold statues in the Netherlands, including Rembrandt statue
  • Suicide a growing trend as more young adults end their lives

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content